Search research articles
Contact Us
Filters
Showing results (1-10 of 23) with videos related to
Page
of 3
Sort By:
Frontiers in Bioscience : a Journal and Virtual Library
|
May 9, 2007
Genetically-engineered animals as research models for atherosclerosis: their use for the characterization of PPAR agonists in the treatment of cardiometabolic disorders
Catherine Fievet, Jean-Charles Fruchart, Bart Staels
BMC Genomics
|
February 5, 2011
Obesity resistant mechanisms in the Lean polygenic mouse model as indicated by liver transcriptome and expression of selected genes in skeletal muscle
Matjaž Simončič, Tadeja Režen, Peter Juvan, et al.
Biochemical and Biophysical Research Communications
|
January 18, 2006
Niemann-Pick C1 like 1 gene expression is down-regulated by LXR activators in the intestine
Caroline Duval, Véronique Touche, Anne Tailleux, et al.
The American Journal of Pathology
|
June 24, 2005
The atheroprotective effect of 17beta-estradiol depends on complex interactions in adaptive immunity
Rima Elhage, Pierre Gourdy, Jacek Jawien, et al.
Journal of Molecular Medicine (Berlin, Germany)
|
September 1, 2005
Increased plasma levels of LDL cholesterol in rabbits after adenoviral overexpression of human scavenger receptor class B type I
Ivan Tancevski, Sasa Frank, Petra Massoner, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 1, 2004
Metabolic syndrome without obesity: Hepatic overexpression of 11beta-hydroxysteroid dehydrogenase type 1 in transgenic mice
Janice M Paterson, Nicholas M Morton, Catherine Fievet, et al.
Biochimica Et Biophysica Acta
|
October 18, 2005
Paradoxical exacerbation of combined hyperlipidemia in human apolipoprotein A-II transgenic mice treated with fenofibrate
Vicent Ribas, Xavier Palomer, Núria Roglans, et al.
The Journal of Biological Chemistry
|
July 18, 2002
Human sterol 27-hydroxylase (CYP27) overexpressor transgenic mouse model. Evidence against 27-hydroxycholesterol as a critical regulator of cholesterol homeostasis
Karen Meir, Daniel Kitsberg, Irit Alkalay, et al.
The Journal of Biological Chemistry
|
September 21, 2010
The farnesoid X receptor regulates adipocyte differentiation and function by promoting peroxisome proliferator-activated receptor-gamma and interfering with the Wnt/beta-catenin pathways
Mouaadh Abdelkarim, Sandrine Caron, Christian Duhem, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
September 30, 2006
Cholesterol 7alpha-hydroxylase deficiency in mice on an APOE*3-Leiden background increases hepatic ABCA1 mRNA expression and HDL-cholesterol
Sabine M Post, Martine Groenendijk, Caroline C van der Hoogt, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 23) with videos related to
Sort By:
Page
of 3
Frontiers in Bioscience : a Journal and Virtual Library
|
May 9, 2007
Genetically-engineered animals as research models for atherosclerosis: their use for the characterization of PPAR agonists in the treatment of cardiometabolic disorders
Catherine Fievet, Jean-Charles Fruchart, Bart Staels
BMC Genomics
|
February 5, 2011
Obesity resistant mechanisms in the Lean polygenic mouse model as indicated by liver transcriptome and expression of selected genes in skeletal muscle
Matjaž Simončič, Tadeja Režen, Peter Juvan, et al.
Biochemical and Biophysical Research Communications
|
January 18, 2006
Niemann-Pick C1 like 1 gene expression is down-regulated by LXR activators in the intestine
Caroline Duval, Véronique Touche, Anne Tailleux, et al.
The American Journal of Pathology
|
June 24, 2005
The atheroprotective effect of 17beta-estradiol depends on complex interactions in adaptive immunity
Rima Elhage, Pierre Gourdy, Jacek Jawien, et al.
Journal of Molecular Medicine (Berlin, Germany)
|
September 1, 2005
Increased plasma levels of LDL cholesterol in rabbits after adenoviral overexpression of human scavenger receptor class B type I
Ivan Tancevski, Sasa Frank, Petra Massoner, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 1, 2004
Metabolic syndrome without obesity: Hepatic overexpression of 11beta-hydroxysteroid dehydrogenase type 1 in transgenic mice
Janice M Paterson, Nicholas M Morton, Catherine Fievet, et al.
Biochimica Et Biophysica Acta
|
October 18, 2005
Paradoxical exacerbation of combined hyperlipidemia in human apolipoprotein A-II transgenic mice treated with fenofibrate
Vicent Ribas, Xavier Palomer, Núria Roglans, et al.
The Journal of Biological Chemistry
|
July 18, 2002
Human sterol 27-hydroxylase (CYP27) overexpressor transgenic mouse model. Evidence against 27-hydroxycholesterol as a critical regulator of cholesterol homeostasis
Karen Meir, Daniel Kitsberg, Irit Alkalay, et al.
The Journal of Biological Chemistry
|
September 21, 2010
The farnesoid X receptor regulates adipocyte differentiation and function by promoting peroxisome proliferator-activated receptor-gamma and interfering with the Wnt/beta-catenin pathways
Mouaadh Abdelkarim, Sandrine Caron, Christian Duhem, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
September 30, 2006
Cholesterol 7alpha-hydroxylase deficiency in mice on an APOE*3-Leiden background increases hepatic ABCA1 mRNA expression and HDL-cholesterol
Sabine M Post, Martine Groenendijk, Caroline C van der Hoogt, et al.
Page
of 3